Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mondelez International A | MDLZ | Nov 18, 2024 | 63.84 | -1.01 |
Moneyhero | MNY | Nov 18, 2024 | 1.19 | +0.85 |
MoneyLion A | ML | Nov 18, 2024 | 80.99 | +2.56 |
MongoDB A | MDB | Nov 18, 2024 | 284.43 | +1.67 |
Monogram Technologies | MGRM | Nov 18, 2024 | 1.99 | -2.93 |
Monolithic Power Systems | MPWR | Nov 18, 2024 | 587.84 | +2.52 |
Monopar Therapeutics | MNPR | Nov 18, 2024 | 18.45 | +1.99 |
Monro | MNRO | Nov 18, 2024 | 28.82 | -0.93 |
Monroe Capital | MRCC | Nov 18, 2024 | 8.44 | +2.55 |
Monster Beverage | MNST | Nov 18, 2024 | 53.27 | +2.44 |
Montana Technologies A | AIRJ | Nov 18, 2024 | 7.33 | -0.68 |
Montauk Renewables | MNTK | Nov 18, 2024 | 4.04 | -1.94 |
Monte Rosa Therapeutics | GLUE | Nov 18, 2024 | 7.54 | -2.58 |
Montrose Environmental Group | MEG | Nov 18, 2024 | 17.79 | -5.77 |
Moodys | MCO | Nov 18, 2024 | 471.94 | -0.29 |
Moog A | MOG-A | Nov 18, 2024 | 217.92 | +1.56 |
Moog B | MOG-B | Nov 18, 2024 | 215.62 | 0.00 |
Moolec Science | MLEC | Nov 18, 2024 | 0.87 | +4.68 |
MoonLake Immunotherapeutics | MLTX | Nov 18, 2024 | 48.54 | -0.59 |
Morgan Stanley | MS | Nov 18, 2024 | 133.78 | -0.21 |
Morgan Stanley China A Share Fund | CAF | Nov 18, 2024 | 12.85 | +0.23 |
Morgan Stanley Direct Lending Fund | MSDL | Nov 18, 2024 | 20.55 | +1.08 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Nov 18, 2024 | 7.59 | +0.26 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Nov 18, 2024 | 4.70 | +1.29 |
Morgan Stanley FXDFR Pref | MS-K | Nov 18, 2024 | 25.12 | -0.16 |
Morgan Stanley India Investment Fund | IIF | Nov 18, 2024 | 27.38 | +0.40 |
Morgan Stanley Pref A | MS-A | Nov 18, 2024 | 23.43 | +0.30 |
Morgan Stanley Pref E | MS-E | Nov 18, 2024 | 25.34 | +0.08 |
Morgan Stanley Pref F | MS-F | Nov 18, 2024 | 25.30 | +0.04 |
Morgan Stanley Pref I | MS-I | Nov 18, 2024 | 25.41 | -0.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.